PedAM

Pediatric Disease Annotations & Medicines

Disease	cystic fibrosis
Symptom	\|lung disease
Sentences	65
PubMedID- 25470304	Authors' conclusions: this review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis.
PubMedID- 22241570	Background: gastro-esophageal reflux (gor) may contribute to lung disease in children with cystic fibrosis (cf).
PubMedID- 20811560	Tuberculosis, including tuberculosis bronchiectasis, bronchogenic carcinoma, and chronic inflammatory lung disease due to bronchiectasis, cystic fibrosis, or aspergillosis are the most common causes of massive hemoptysis .
PubMedID- 20717938	Summary: lung disease in patients with cystic fibrosis (cf) is characterized by recurrent bacterial respiratory infections and intense airway inflammation.
PubMedID- 20840889	Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it.
PubMedID- 23378408	Hrct has an advantage over conventional chest x-rays in the evaluation of the stage and progression of lung disease in patients with cystic fibrosis.
PubMedID- 25216826	Mycobacterium abscessus complex is a group of rapidly growing mycobacteria, and an emerging cause of non-tuberculous mycobacterial lung disease in patients with cystic fibrosis and chronic lung diseases, such as bronchiectasis.
PubMedID- 21494150	Purpose of review: lung disease in cystic fibrosis (cf) results from chronic airway infection and inflammation leading to progressive bronchiectasis and respiratory failure.
PubMedID- 25963404	Background: cystic fibrosis (cf) leads to advanced lung disease despite aggressive care.
PubMedID- 20435528	Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research which areas to target.
PubMedID- 20427819	The development of lung disease in cystic fibrosis pigs.
PubMedID- 23235684	Authors' conclusions: this review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis.
PubMedID- 22035707	We describe the successful use of ambulatory single-venous vv ecmo as a bridge to bilateral lung transplantation in 4 patients with end-stage lung disease due to cystic fibrosis who developed acute hypercapnic respiratory failure.
PubMedID- 25222938	Pulmonary hypertension in cystic fibrosis with advanced lung disease.
PubMedID- 22323305	Rationale: unrecognized airway infection and inflammation in young children with cystic fibrosis (cf) may lead to irreversible lung disease; therefore early detection and treatment is highly desirable.

Page: 1 2